Sensitivity Of Her2-Amplified Colorectal Organotypic Cancer Spheroids At Ex Vivo Resistance To Panitumumab And Trastuzumab.

Jeremy D. Kratz, Lucas Zarling,Aishwarya Sunil,Shujah Rehman,Katherine Anne Johnson,Sarbjeet K. Makkar,Cheri Pasch,Nicole Lassen,Kayla Lemmon,Linda Clipson,Sam Joseph Lubner,Melissa C. Skala,Dustin A. Deming

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用 0|浏览1

暂无评分

摘要

68Background: HER2 amplification is an emerging biomarker in colorectal cancer (CRC) with increased copy number associated with improved clinical outcomes to HER2 targeting. RAS/RAF wildtype CRC al...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要